Cargando…
MON-558 Radioiodine Is Not Associated with Quality of Life Outcomes in Early Stage Thyroid Cancer Survivors, a Matched-Pair Analysis.
Background: Radioiodine ablation (RAI) is often given as adjuvant therapy following thyroidectomy for differentiated thyroid cancer (DTC). The benefits of RAI are unclear in low-risk DTC, and the effects of RAI on health-related quality of life (HRQoL) are not well described. We hypothesized RAI wou...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550947/ http://dx.doi.org/10.1210/js.2019-MON-558 |